{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:31:29Z","timestamp":1762144289761},"reference-count":56,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1016\/j.ejphar.2004.03.006","type":"journal-article","created":{"date-parts":[[2004,4,15]],"date-time":"2004-04-15T09:36:43Z","timestamp":1082021803000},"page":"157-165","source":"Crossref","is-referenced-by-count":31,"title":["Cabergoline protects SH-SY5Y neuronal cells in an in vitro model of ischemia"],"prefix":"10.1016","volume":"489","author":[{"given":"Gianluca","family":"Miglio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Varsaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Francioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Battaglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pier Luigi","family":"Canonico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grazia","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2004.03.006_BIB1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0167-4889(99)00110-X","article-title":"In the neuronal cell line SH-SY5Y, oxidative stress-induced free radical overproduction causes cell death without any participation of intracellular Ca2+ increase","volume":"1452","author":"Amoroso","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2004.03.006_BIB2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000058049","article-title":"Efficacy of cabergoline in long-term use: results of three observational studies in 1500 patients with Parkinson's disease","volume":"46","author":"Baas","year":"2001","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.ejphar.2004.03.006_BIB3","first-page":"5712","article-title":"Loss of lipid peroxidation as a histochemical marker for preneoplastic hepatocellular foci of rats","volume":"44","author":"Benedetti","year":"1984","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2004.03.006_BIB4","first-page":"3751","article-title":"Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones","volume":"38","author":"Biedler","year":"1978","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2004.03.006_BIB5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1749-6632.1989.tb14904.x","article-title":"Vitamin E as an in vitro and in vivo antioxidant","volume":"570","author":"Burton","year":"1989","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejphar.2004.03.006_BIB6","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1002\/neu.480230915","article-title":"Excitotoxic cell death","volume":"23","author":"Choi","year":"1992","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.ejphar.2004.03.006_BIB7","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0306-4522(92)90249-2","article-title":"l-glutamate-evoked release of dopamine from synaptosomes of the rat striatum: involvement of AMPA and N-methyl-d-aspartate receptors","volume":"47","author":"Desce","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2004.03.006_BIB8","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0891-5849(98)00157-9","article-title":"Vitamin E enhances Ca2+-mediated vulnerability of immature cerebellar granule cells to ischemia","volume":"25","author":"Dyatlov","year":"1998","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2004.03.006_BIB9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2165\/00003495-199855001-00002","article-title":"Pharmacodynamic and pharmacokinetic features of cabergoline. Rationale for use in Parkinson's disease","volume":"55","author":"Fariello","year":"1998","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2004.03.006_BIB10","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/0024-3205(94)00520-6","article-title":"Induction of adenylate cyclase sensitive dopamine D2-receptors in retinoic acid induced differentiated human neuroblastoma SHSY-5Y cells","volume":"55","author":"Farooqui","year":"1994","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2004.03.006_BIB11","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1006\/phrs.2000.0690","article-title":"Reduction of lipid peroxidation in different rat brain areas after cabergoline treatment","volume":"42","author":"Finotti","year":"2000","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2004.03.006_BIB12","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1523\/JNEUROSCI.13-08-03510.1993","article-title":"Combined oxygen and glucose deprivation in cortical cell culture: calcium-dependent and calcium-independent mechanisms of neuronal injury","volume":"13","author":"Goldberg","year":"1993","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2004.03.006_BIB13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0006-8993(96)00968-7","article-title":"Neuroprotective effects of the dopamine D2\/D3 agonist pramipexole against postischemic or methamphetamine-induced degeneration of nigrostriatal neurons","volume":"742","author":"Hall","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2004.03.006_BIB14","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1046\/j.1471-4159.2002.01198.x","article-title":"Neuroprotective effects of bcl-2 overexpression in hippocampal cultures: interactions with pathways of oxidative damage","volume":"83","author":"Howard","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2004.03.006_BIB15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1006\/exnr.1996.6374","article-title":"Mechanisms of dopamine-induced cell death in cultured rat forebrain neurons: interactions with and differences from glutamate-induced cell death","volume":"143","author":"Hoyt","year":"1997","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2004.03.006_BIB16","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/0006-8993(95)01120-X","article-title":"1-Methyl-4-phenyl-pyridinium ion (MPP+) causes DNA fragmentation and increases the Bcl-2 expression in human neuroblastoma, SH-SY5Y cells, through different mechanisms","volume":"704","author":"Itano","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2004.03.006_BIB17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/33.1.2578146","article-title":"An improved method to determine cell viability by simultaneous staining with fluorescein diacetate\u2013propidium iodide","volume":"33","author":"Jones","year":"1985","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.ejphar.2004.03.006_BIB18","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/jnr.10426","article-title":"Protective effect of dopamine D2 agonists in cortical neurons via the phosphatidylinositol 3 kinase cascade","volume":"70","author":"Kihara","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ejphar.2004.03.006_BIB19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1440-1681.1995.tb02003.x","article-title":"Ca2+-dependent and -independent mechanisms of ischaemia-evoked release of [3H]-dopamine from rat striatal slices","volume":"22","author":"Kim","year":"1995","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ejphar.2004.03.006_BIB20","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1124\/mol.54.6.1046","article-title":"Protective effects of the antiparkinsonian drugs talipexole and pramipexole against 1-methyl-4-phenylpyridinium-induced apoptotic death in human neuroblastoma SH-SY5Y cells","volume":"54","author":"Kitamura","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.03.006_BIB21","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1023\/A:1023207222944","article-title":"Neuroprotective mechanisms of antiparkinsonian dopamine D2-receptor subfamily agonists","volume":"28","author":"Kitamura","year":"2003","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejphar.2004.03.006_BIB22","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0006-2952(96)00731-9","article-title":"Dopamine- and l-beta-3,4-dihydroxyphenylalanine hydrochloride (l-Dopa)-induced cytotoxicity towards catecholaminergic neuroblastoma SH-SY5Y cells. Effects of oxidative stress and antioxidative factors","volume":"53","author":"Lai","year":"1997","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.03.006_BIB23","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1212\/WNL.25.5.483","article-title":"Brain H-3-catecholamine metabolism in experimental cerebral ischemia","volume":"25","author":"Lavyne","year":"1975","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2004.03.006_BIB24","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1152\/physrev.1999.79.4.1431","article-title":"Ischemic cell death in brain neurons","volume":"79","author":"Lipton","year":"1999","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejphar.2004.03.006_BIB25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0022-510X(94)00239-K","article-title":"Bromocriptine protects against delayed neuronal death of hippocampal neurons following cerebral ischemia in the gerbil","volume":"129","author":"Liu","year":"1995","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ejphar.2004.03.006_BIB26","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0014-2999(02)02683-3","article-title":"Cabergoline prevents necrotic neuronal death in an in vitro model of oxidative stress","volume":"457","author":"Lombardi","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.03.006_BIB27","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/0006-8993(75)90021-9","article-title":"Putative neurotransmitters and cyclic nucleotides in prolonged ischemia of the cerebral cortex","volume":"98","author":"Lust","year":"1975","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2004.03.006_BIB28","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1046\/j.1471-4159.2002.01169.x","article-title":"Striatal dopamine\u2013NMDA receptor interactions in the modulation of glutamate release in the substantia nigra pars reticulata in vivo: opposite role for D1 and D2 receptors","volume":"83","author":"Marti","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2004.03.006_BIB29","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0361-9230(98)00024-0","article-title":"Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: a perspective on the contributions of apoptosis and necrosis","volume":"46","author":"Martin","year":"1998","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2004.03.006_BIB30","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0892-0362(02)00214-3","article-title":"DOPA causes glutamate release and delayed neuron death by brain ischemia in rats","volume":"24","author":"Misu","year":"2002","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.ejphar.2004.03.006_BIB31","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/sj.cdd.4400884","article-title":"Poly(ADP-ribose) polymerase inhibitors attenuate necrotic but not apoptotic neuronal death in experimental models of cerebral ischemia","volume":"8","author":"Moroni","year":"2001","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejphar.2004.03.006_BIB32","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ejphar.2004.03.006_BIB33","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1053\/apmr.2001.25149","article-title":"Dopaminergic therapy with carbidopa l-dopa for left neglect after stroke: a case series","volume":"82","author":"Mukand","year":"2001","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.ejphar.2004.03.006_BIB34","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0306-4522(93)90527-M","article-title":"Aluminum silicate toxicity in cell cultures","volume":"55","author":"Murphy","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2004.03.006_BIB35","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1046\/j.1471-4159.1996.66062390.x","article-title":"Interaction of NMDA and dopamine D2L receptors in human neuroblastoma SH-SY5Y cells","volume":"66","author":"Nair","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2004.03.006_BIB36","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejphar.2004.03.006_BIB37","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/978-1-4684-7971-3_48","article-title":"Inciting excitotoxic cytocide among central neurones","volume":"203","author":"Olney","year":"1986","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ejphar.2004.03.006_BIB38","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0014-2999(98)00333-1","article-title":"Dopamine D2 receptor agonists protect against ischaemia-induced hippocampal neurodegeneration in global cerebral ischaemia","volume":"352","author":"O'Neill","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.03.006_BIB39","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1034\/j.1600-079X.2003.00026.x","article-title":"Melatonin protects SHSY5Y neuronal cells but not cultured astrocytes from ischemia due to oxygen and glucose deprivation","volume":"34","author":"Pei","year":"2003","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.ejphar.2004.03.006_BIB40","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1111\/j.1471-4159.1988.tb01187.x","article-title":"Excitatory amino acid release from rat hippocampal slices as a consequence of free-radical formation","volume":"51","author":"Pellegrini-Giampietro","year":"1988","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2004.03.006_BIB41","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/jcb.10506","article-title":"Anti-apoptotic defence of bcl-2 gene against hydroperoxide-induced cytotoxicity together with suppressed lipid peroxidation, enhanced ascorbate uptake, and upregulated Bcl-2 protein","volume":"89","author":"Saitoh","year":"2003","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ejphar.2004.03.006_BIB42","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1212\/WNL.58.suppl_1.S9","article-title":"Neuroprotection and dopamine agonists","volume":"58","author":"Schapira","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2004.03.006_BIB43","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0140-6736(01)05966-9","article-title":"Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, double-blind study","volume":"358","author":"Scheidtmann","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2004.03.006_BIB44","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3171\/jns.1992.77.2.0169","article-title":"Pathophysiology and treatment of focal cerebral ischemia: Part I. Pathophysiology","volume":"77","author":"Siesjo","year":"1992","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.ejphar.2004.03.006_BIB45","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3171\/jns.1992.77.3.0337","article-title":"Pathophysiology and treatment of focal cerebral ischemia: Part II. Mechanisms of damage and treatment","volume":"77","author":"Siesjo","year":"1992","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.ejphar.2004.03.006_BIB46","doi-asserted-by":"crossref","first-page":"C772","DOI":"10.1152\/ajpcell.1998.275.3.C772","article-title":"Stimulation of Na+\u2013K+\u20132Cl\u2212 cotransporter in neuronal cells by excitatory neurotransmitter glutamate","volume":"275","author":"Sun","year":"1998","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2004.03.006_BIB47","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0006-8993(00)02493-8","article-title":"Increase of Bcl-2 protein in neuronal dendritic processes of cerebral cortex and hippocampus by the antiparkinsonian drugs, talipexole and pramipexole","volume":"872","author":"Takata","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2004.03.006_BIB48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1523\/JNEUROSCI.20-01-j0006.2000","article-title":"NADPH oxidase contributes directly to oxidative stress and apoptosis in nerve growth factor-deprived sympathetic neurons","volume":"20","author":"Tammariello","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2004.03.006_BIB49","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0014-2999(01)01537-0","article-title":"Pergolide protects SH-SY5Y cells against neurodegeneration induced by H2O2","volume":"434","author":"Uberti","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.03.006_BIB50","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0891-5849(93)90078-9","article-title":"Molecular pharmacology of vitamin E: structural aspects of antioxidant activity","volume":"15","author":"van Acker","year":"1993","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2004.03.006_BIB51","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1471-4159.1991.tb08224.x","article-title":"Presynaptic glutamate receptors modulate dopamine release from striatal synaptosomes","volume":"57","author":"Wang","year":"1991","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2004.03.006_BIB52","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00004647-200202000-00008","article-title":"Role of intracellular calcium stores in cell death from oxygen\u2013glucose deprivation in a neuronal cell line","volume":"22","author":"Wang","year":"2002","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.ejphar.2004.03.006_BIB53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3940(02)00594-3","article-title":"Antioxidant properties of cabergoline: inhibition of brain auto-oxidation and superoxide anion production of microglial cells in rats","volume":"330","author":"Yoshida","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2004.03.006_BIB54","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0168-0102(02)00040-8","article-title":"The dopamine agonist cabergoline provides neuroprotection by activation of the glutathione system and scavenging free radicals","volume":"43","author":"Yoshioka","year":"2002","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.ejphar.2004.03.006_BIB55","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1046\/j.1471-4159.2003.01756.x","article-title":"Bcl-2 overexpression protects against neuron loss within the ischemic margin following experimental stroke and inhibits cytochrome c translocation and caspase-3 activity","volume":"85","author":"Zhao","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2004.03.006_BIB56","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2174\/1566524033479717","article-title":"Stroke: molecular mechanisms and potential targets for treatment","volume":"3","author":"Zheng","year":"2003","journal-title":"Curr. Mol. Med."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299904002195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299904002195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T01:29:48Z","timestamp":1550107788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299904002195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S0014299904002195"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2004.03.006","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}